ACP’s New Guidance Endorses Two COVID-19 Drugs, Advises Against Two
ACP issued four practice points on the pharmacologic and biologic treatment of COVID-19 in the outpatient setting, endorsing two drugs and advising against two others.
ACP issued four practice points on the pharmacologic and biologic treatment of COVID-19 in the outpatient setting, endorsing two drugs and advising against two others.
Researchers have discovered some new and surprising ways that viral RNA and influenza viruses are detected by human lung cells, which have potential implications for treating people affected by such viruses.
A new study finds SARS-CoV-2 infection is significantly associated with the development of high blood pressure in adults with preexisting heart conditions or those who were older, Black, or male.
Scientists are providing one of the first snapshots of the interplay among these three common but potentially deadly viruses.
A Phase 2 study has begun for a novel first-in-class anti-infective agent to treat severe community-acquired bacterial pneumonia (SCABP).
Half as many children in the United States were diagnosed with asthma in the first year of the COVID-19 pandemic compared to previous years, perhaps due to a fewer number of common colds, according to Rutgers University researchers.
A new study illuminates two major mechanisms underlying high risks from lung infections in Down syndrome patients.